Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Meng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4970-8590; OpenAlex author ID A5100377165. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: 2 papers

Papers 6

  1. KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. Co-author DOI 10.1007/s00018-024-05442-6↗
  2. Solute carrier family 16 member 1 as a potential prognostic factor for pancreatic ductal adenocarcinoma and its influence on tumor immunity. Co-author DOI 10.21037/jgo-24-147↗
  3. Ligustrazine-Derived Chalcones-Modified Platinum(IV) Complexes Intervene in Cisplatin Resistance in Pancreatic Cancer through Ferroptosis and Apoptosis. Co-author DOI 10.1021/acs.jmedchem.3c00922↗
  4. Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone… Co-author DOI 10.1186/s12885-023-10529-7↗
  5. S-1 plus CIK as second-line treatment for advanced pancreatic cancer. Co-author DOI 10.1007/s12032-013-0747-9↗
  6. Phase II trial of capecitabine combined with thalidomide in second-line treatment of advanced pancreatic cancer. First author DOI 10.1016/j.pan.2012.09.007↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenna Jiang · 2 shared papers, 2024 · strength 0.40
  2. Duo Zuo · 1 shared paper, 2024 · strength 0.20
  3. Lu Qiao · 1 shared paper, 2024 · strength 0.20
  4. Li Ren · 1 shared paper, 2024 · strength 0.20
  5. Tianxing Zhou · 1 shared paper, 2024 · strength 0.20
  6. Jing Liu · 1 shared paper, 2024 · strength 0.20
  7. Abhinav V. Reddy · 1 shared paper, 2024 · strength 0.20
  8. Shinichi Ikuta · 1 shared paper, 2024 · strength 0.20
  9. Alice Talbot · 1 shared paper, 2024 · strength 0.20
  10. Li Ren · 1 shared paper, 2024 · strength 0.20
  11. Heng‐Shan Wang · 1 shared paper, 2023 · strength 0.19
  12. Xiang Li Ma · 1 shared paper, 2023 · strength 0.14
  13. Risheng Que · 1 shared paper, 2023 · strength 0.14
  14. Jun Yu · 1 shared paper, 2023 · strength 0.14
  15. Min Zhang · 1 shared paper, 2023 · strength 0.14
  16. Tingbo Liang · 1 shared paper, 2023 · strength 0.14
  17. Xueli Bai · 1 shared paper, 2023 · strength 0.14
  18. Jing Tian · 1 shared paper, 2013 · strength 0.05
  19. Quan-yun Liu · 1 shared paper, 2012 · strength 0.04
  20. Shengbin Shi · 1 shared paper, 2012 · strength 0.04
  21. Zuoxing Niu · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.